They found that the activation of Nrf2 in liver cells of PBC patients was enhanced after UDCA treatment and thioredoxin (TRX) and thioredoxin reductase 1 (TrxR1) protein significantly increased (Figure 5) (Kawata et al., 2010). The gene discussed is TXN; the disease is primary biliary cholangitis.